Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer

Clinical trial NCT07066995 · RECRUITING

Trial details

NCT number: NCT07066995
Sponsor: Essen Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Pancreatic Carcinoma Pancreatic Cancer Non-resectable Pancreatic Cancer Stage IV

Start date: 2025-04-29
Primary completion: 2027-12-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.